Reuters: Immunotherapy may benefit allergic preschoolers

[NaDiNe]

Immunotherapy may benefit allergic preschoolers
      

NEW YORK (Reuters Health) - Although there is controversy over the use of immunotherapy among children younger than 6 years old, a new study shows that it is safe and effective for the treatment of hayfever in this age group and may prevent the later development of more allergies and asthma.</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login